Piper Sandler Reiterates Overweight on Sight Sciences, Raises Price Target to $12
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsReiterationPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Piper Sandler analyst Adam Maeder reiterates Sight Sciences (NASDAQ:SGHT) with a Overweight and raises the price target from $9 to $12.
Piper Sandler analyst Adam Maeder reiterates Sight Sciences (NASDAQ:SGHT) with a Overweight and raises the price target from $9 to $12.
